Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
House of Representatives, Congress."
House Hearing, 104th Congress
- OFF-LABEL DRUG USE AND FDA REVIEW OF SUPPLEMENTAL DRUG APPLICATION. Government. U.S. Government Printing Office https://www.govinfo.gov/app/details/CHRG-104hhrg44757.
APA
House of Representatives, Congress. (1996, September 12). House Hearing, 104th Congress - OFF-LABEL DRUG USE AND FDA REVIEW OF SUPPLEMENTAL DRUG APPLICATION. [Government]. U.S. Government Printing Office. https://www.govinfo.gov/app/details/CHRG-104hhrg44757
MLA
House of Representatives, Congress. House Hearing, 104th Congress - OFF-LABEL DRUG USE AND FDA REVIEW OF SUPPLEMENTAL DRUG APPLICATION. U.S. Government Printing Office, (12 Sep 1996), https://www.govinfo.gov/app/details/CHRG-104hhrg44757
Bluebook
House of Representatives, Congress, OFF-LABEL DRUG USE AND FDA REVIEW OF SUPPLEMENTAL DRUG APPLICATION, GovInfo, (September 12, 1996), https://www.govinfo.gov/app/details/CHRG-104hhrg44757
